Jord H.A. Nagel

Netherlands Forensic Institute — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index1.4kcitations38works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

BRCA gene mutations in cancer(11), Glioma Diagnosis and Treatment(9), Protein Kinase Regulation and GTPase Signaling(5), RNA and protein synthesis mechanisms(5), CRISPR and Genetic Engineering(5)

Publications38 total

Fast DNA reports for investigative leads in casework practice: An automated workflow for mixture analysis using database searching based on probabilistic genotyping
Forensic Science International Synergy·2025Open Access
Supplementary Table S1 from Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
2023Open Access
Data from Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
2023Open Access
Data from Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
2023Open Access
Supplementary Table S1 from Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
2023Open Access
Supplementary Table 3 from Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
2023Open Access
Data from Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
2023Open Access
Data from Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
2023Open Access
Supplementary Figure Legends from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
Supplementary Figure Legends from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
Supplementary Table 3 from Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
2023Open Access
Supplementary Figure S1 from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
Data from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
Supplementary Tables 1-2 from Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
2023Open Access
Supplementary Figure S2 from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
Supplementary Figure S1 from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
Supplementary Figure S2 from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
Supplementary Tables 1-2 from Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
2023Open Access
Supplementary Table 3 from Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
2023Open Access
Data from <i>BRCA1</i> Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Mieke Schutte(18), Antoinette Hollestelle(16), Fons Elstrodt(16), Marijke Wasielewski(13), Peter J. van der Spek(12), Pim J. French(11), Ans van den Ouweland(11), Stephen P. Ethier(10), Peter A. Sillevis Smitt(10), Michael A. Gorin(9), Sofía D. Merajver(9), Sigrid Swagemakers(9), Mathilde C.M. Kouwenhoven(9), Eric Brouwer(9), Theo M. Luider(9), Johan M. Kros(9), Martin J. van den Bent(9), Wouter W. Kallemeijn(5), Corina C.G. Benschop(4), Justine Peeters(3)